| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.23 | 2e-05 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.22 | 3e-05 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.14 | 0.008 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.15 | 0.01 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.13 | 0.03 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.14 | 0.04 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.089 | 0.07 |